Resultados de la búsqueda 31-40 of 271 for 서산안마🉐 ┘OPDAL010.COM└오피달리기 🌪서산휴게텔🌥서산출장안마🌉서산대딸방👨서산오피👨서산마사지🔰서산휴게텔🌄

  1. Neurología - Ensayos clínicos - Mayo Clinic

    Clinical and Basic Investigations into Phosphomannomutase deficiency (PMM2-CDG) This is a natural history (observational) protocol designed to collect ...

  2. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIED) ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    Clinical and Basic Investigations into Phosphomannomutase deficiency (PMM2-CDG) This is a natural history (observational) protocol designed to collect ...

  4. Estar en forma Noticias de la Mayo Clinic

    News. septiembre 2024. Perimenopause, menopause and ... weightlifting? Expert explains value for bone health Sept. 04, 2024, 03:15 p.m. CDT ...

  5. La salud de adolescentes y preadolescentes - Mayo Clinic

    News · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024 · junio 2024 · mayo 2024 · abril 2024 · marzo 2024.

  6. Neurología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to identify important physiologic trends in bedside ICU data such as cerebral perfusion pressure (CPP), intracranial pressure (ICP) ...

  9. Estar en forma Noticias de la Mayo Clinic

    News. septiembre 2024. Perimenopause, menopause and ... weightlifting? Expert explains value for bone health Sept. 04, 2024, 03:15 p.m. CDT ...

  10. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR).